Old Web
English
Sign In
Acemap
>
Paper
>
MUTATIONAL PROFILE BY NGS COMBINED WITH EX VIVO DRUG SENSITIVITY PROFILE IMPROVE PREDICTION OF AML PATIENT OUTCOME: PF221
MUTATIONAL PROFILE BY NGS COMBINED WITH EX VIVO DRUG SENSITIVITY PROFILE IMPROVE PREDICTION OF AML PATIENT OUTCOME: PF221
2019
Onecha E. De La Fuente
Ruiz Y. Heredia
Linares M. Gomez
David Martínez-Cuadrón
Inmaculada Rapado
Martinez P. Sanchez
Juarez A. Rufian
Sargas C. Simarro
Blanca Boluda
E Acuña
Cano I
Pau Montesinos
Eva Barragán
J. L. Rojas
Julian Gorrochategui
J.C. Ballesteros
Martínez J. López
Ayala R. Diaz
Keywords:
Ex vivo
Internal medicine
Drug
Oncology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]